MariMed seeks stockholder approval for a reverse stock split
Tweet Send to a Friend
MariMed Inc. (CSE: MRMD) (OTCQB: MRMD) has filed a definitive proxy statement with the U.S. Securities and Exchange Commission seeking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


